Utilizing TRIPS Flexibilities for Public Health Protection Through South-South Regional Frameworks
(2004; 110 pages) [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoTHE SOUTH CENTRE
Ver el documentoPREFACE
Ver el documentoABBREVIATIONS
Ver el documentoEXECUTIVE SUMMARY
Abrir esta carpeta y ver su contenidoI. INTRODUCTION
Abrir esta carpeta y ver su contenidoII. INTELLECTUAL PROPERTY AND ACCESS TO ESSENTIAL MEDICINES IN DEVELOPING COUNTRIES
Cerrar esta carpetaIII. CONSTRAINTS ON NATIONAL EFFORTS TO IMPLEMENT TRIPS FLEXIBILITIES FOR PUBLIC HEALTH PURPOSES
Ver el documentoIII.1 Lack of Technical Expertise to Incorporate and Implement TRIPS Flexibilities in National Law and Policy
Ver el documentoIII.2 Insufficient Domestic Research and Manufacturing Capacities in the Pharmaceutical Sector
Ver el documentoIII.3 Insufficient Technical and Infrastructural Capacities for Medicines Regulation
Ver el documentoIII.4 Difficulties in Establishing Efficient Pharmaceutical Management and Procurement Systems
Ver el documentoIII.5 Bilateral and other TRIPS-plus Pressures
Ver el documentoIII.6 Difficulties in Tackling Anti-Competitive Practices and Abuse of Intellectual Property Rights
Abrir esta carpeta y ver su contenidoIV. OVERCOMING CONSTRAINTS IN THE USE OF TRIPS FLEXIBILITIES THROUGH SOUTH-SOUTH REGIONAL FRAMEWORKS
Abrir esta carpeta y ver su contenidoV. CONCLUSIONS AND RECOMMENDATIONS
Ver el documentoBIBLIOGRAPHY
Ver el documentoBACK COVER
 

III.4 Difficulties in Establishing Efficient Pharmaceutical Management and Procurement Systems

Another challenge that faces developing countries in their efforts to improve availability and access to essential medicines relates to establishing efficient pharmaceutical management and procurement systems. Putting in place efficient management systems for pharmaceutical procurement can be a costly and complex process requiring vast resources and technical know-how. The problems can be particularly acute for small countries whose average drug prices are generally high due to lack of economies of scale. The cost of taking care of quality and supply chain issues is also high.

The lack of efficient and cost-effective management and procurement systems therefore has an effect on prices, on quality, on rational use of drugs as well as on availability of medicines generally. Consequently, the use of TRIPS flexibilities to improve availability and access to medicines faces challenges due to lack of resources and technical expertise to administer efficient pharmaceutical management and procurement systems.

Ir a la sección anterior
Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019